DetailsMembership Status
Registration Date: Jun 05, 2005Usergroup: admin
Trader Rating: 0
Listings Submitted: 81 listings
Total Comments: 0 (0 per day)
Total Time Online: 0 days, 2 hours and 30 minutes
Last seen: 04/18/11 - 10:39:06
Biographical Information
Contact Information
Guestbook: View or sign guestbook (0)Submission History
Most recent listings:Find all listings submitted by mbrose
Santhera
URL: http://www.santhera.com/Description: Santhera Pharmaceuticals AG is a Swiss biopharmaceutical company founded in 2004 through a merger between Germany-based Graffinity Pharmaceuticals AG and Swiss-based MyoContract AG. Santhera is focused on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases and has a fully integrated platform for the discovery and development of drug candidates. The company, headquartered in Switzerland, has operations in Liestal, Switzerland (near Basel) and in Heidelberg, Germany, as well as a business development office in Boston, MA, USA. Santhera's investors comprise Merlin Biosciences Limited, Oxford Bioscience Partners, NGN Capital, 3i Group plc, Carnegie Asset Management, The Novartis Venture Fund, Varuma AG, GIMV, Clariden Bank, The Dow Chemical Company, Heidelberg Innovation, TechnoStart, tbg, the Swiss Foundation for Research on Muscle Diseases, and private investors.
Submitted: 08/03/05 (Edited 08/03/05)
Views: 305 views. Averaging 0 views per day.
In the most recent 30 day period, there've been 0 views.
Discussion: 0 comments
Print
Rate
Discussion (0)
Report